Skip to content
Home/Companies/Biotech/Apollo Therapeutics

Apollo Therapeutics

Biotech·UK·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns Apollo Therapeutics?

Apollo Therapeutics is currently owned by IP Group through IP Group (Evergreen) (2001 vintage), since 2017.

Hand-verified · updated 2026-08-12

IP Group
Investor
IP Group
IP Group (Evergreen) · 2001 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive

More from IP Group (Evergreen)

Other portfolio companies in the same fund.

Mantle8
Mantle8
Active
ClimateTechFrance· 2025
AirForestry
Active
ClimateTechSweden· 2024
Lumai
Lumai
Active
AI/MLUK· 2022
Atisama Therapeutics
Active
BiotechAustralia· 2021
Centessa Pharmaceuticals
Centessa Pharmaceuticals
Active
BiotechUS· 2021
Hysata
Active
ClimateTechAustralia· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Apollo Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Apollo Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue